Sarcoidosis decisions — 2017
90 indexed Board decisions in 2017.
Badges describe the whole decision, not the outcome for every condition listed. An appeal can grant one issue and deny or remand another. Check the original decision for each issue; these outcomes do not predict your claim.
- Whole decision: DeniedMarch 2017
The Board has determined that the Veteran's sarcoidosis, respiratory disorder (claimed as asthma), and headaches disabilities are not related to his military service.
- Whole decision: Remanded (sent back)February 2017
The Board has remanded the Veteran's claims for additional development due to a misplaced portion of his file. The case will be returned to the AOJ for further action.
- Whole decision: DismissedFebruary 2017
The Veteran has withdrawn his appeals for the issues of entitlement to service connection for sleep apnea, gastrointestinal reflux disease (GERD), and sarcoidosis. As a result, these claims are dismissed.
- Whole decision: Remanded (sent back)February 2017
The Board has remanded the case for further development, including obtaining an addendum opinion from a VA examiner to address whether it is at least as likely as not that any currently diagnosed respiratory disorder, to include pulmonary asbestosis and sarcoidosis of lung, was caused by or resulted from the Veteran's military service.
- Whole decision: Remanded (sent back)February 2017
The Board has reopened the Veteran's claim of service connection for COPD, but further development is needed to address his respiratory disabilities and other claims.
- Whole decision: DeniedFebruary 2017
The Board has determined that the Veteran's respiratory disorders, including sarcoidosis, obstructive sleep apnea, and asthma, are not related to his active duty service, including any asbestos exposure.
- Whole decision: GrantedFebruary 2017
The Board has determined that the Veteran's sarcoidosis manifested to a compensable degree within one year of his separation from service, and therefore grants entitlement to service connection for sarcoidosis.
- Whole decision: DeniedFebruary 2017
The Veteran's sarcoidosis, at its worst, was manifested by post-bronchodilator FEV-1 of 59 percent predicted or pulmonary involvement with persistent symptoms requiring chronic low dose corticosteroids. The Board found a rating in excess of 30 percent is not warranted.
- Whole decision: DeniedJanuary 2017
The Board denied the Veteran's claims for service connection for sarcoidosis, asthma, hypertension, and OSA as secondary to sarcoidosis. The evidence did not support a finding of in-service onset or association with any of these conditions.
- Whole decision: Remanded (sent back)January 2017
The Board has remanded the case for additional development, including obtaining medical records and scheduling a VA examination to assess the severity of the Veteran's sarcoidosis. The issues on appeal are related to hypertension, asthma, and right lung sarcoidosis.
← Back to Sarcoidosis overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.